Home » Gene and Cell Therapy Services » AAV Vector CDMO Services

AAV Vector CDMO Services

AAV Vector CDMO Services

Gene and cell therapy (GCT) has the potential to transform medicine, providing long term and potentially curative treatment options for a wide range of diseases. AAV vector is the most widely used vehicle in delivering gene of interest (GOI) in in vivo gene therapies.

GenScript ProBio is aimed to solve difficulties in producing AAV vector, and is expanding its business into AAV services to cover various needs from research through IND application to clinical trials.

  • AAV Services
  • Research &

    Pilot Study

      IND Filing

    Phase I  

    Phase II

    Phase III


    GMP Clinical AAV

Our Services

  • ProAAV Manufacturing

    Adopting most relevant GMP features, ProAAV fulfills your expectation in non-clinical phases.

  • AAV One-stop Solution

    Covering the process development, analytical development, GMP manufacturing and stability; supporting regulatory filings.

  • GMP AAV Manufacturing

    Coming Soon!

Our Facility and Experience

    • 2,500 m2 state-of-the-art facility dedicated for viral vectors manufacturing
    • Global partnerships on viral vector projects
    • Assisted 3 clients to get IND clearance

Related Products